Kardigan · 9 hours ago
2026 Summer Intern - Corporate Strategy (MBA)
Kardigan is a heart health company focused on making cardiovascular disease preventable and curable. They are seeking a highly motivated MBA intern to support the Corporate Strategy team by developing analyses and insights that shape key decisions across the company.
Artificial Intelligence (AI)BiopharmaHealth CareMedical
Responsibilities
Support the development of enterprise, business unit, disease area, and asset-level strategies through structured analysis and strategic problem solving
Conduct market, competitive, and landscape assessments across cardiovascular therapeutics, digital health, and adjacent areas
Evaluate new business concepts and strategic opportunities, including potential partnerships and adjacencies
Build quantitative and qualitative analyses (e.g., market sizing, competitive benchmarking, scenario modeling) to inform strategic discussions
Develop clear, executive-ready presentations to communicate findings and recommendations
Partner with cross-functional teams—R&D, Clinical, Commercial, Finance, and others—to gather inputs and synthesize insights
Translate complex information into concise, structured insights that support decision-making
Present final findings and recommendations to the corporate strategy team and relevant leaders
Qualification
Required
First-year MBA students enrolled full-time graduating between December 2026 and June 2027
Prior experience / interest in healthcare industry (biotechnology, pharma, med tech, etc.)
Strong analytical and structured problem‑solving capabilities
Advanced proficiency in PowerPoint and Excel, including building executive presentations and performing quantitative analysis
Excellent written and verbal communication skills
Proven ability to work independently and manage multiple priorities in a fast-paced environment
Company
Kardigan
Kardigan develops personalized medicines using AI and data to target and treat the root causes of cardiovascular diseases.
Funding
Current Stage
Growth StageTotal Funding
$554MKey Investors
ARCH Venture Partners,Perceptive Advisors,Sequoia Heritage
2025-10-14Series B· $254M
2025-01-10Series A· $300M
Recent News
2025-12-16
2025-11-19
Company data provided by crunchbase